Related references
Note: Only part of the references are listed.Aspirin and cancer risk: a quantitative review to 2011
C. Bosetti et al.
ANNALS OF ONCOLOGY (2012)
Incidence, treatment options, and outcomes of lung cancer in patients with chronic obstructive pulmonary disease
Clara Schroedl et al.
CURRENT OPINION IN PULMONARY MEDICINE (2012)
ARE THE RESULTS OF RTOG 0617 MYSTERIOUS?
James D. Cox
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Results of Proton Beam Therapy without Concurrent Chemotherapy for Patients with Unresectable Stage III Non-small Cell Lung Cancer
Yoshiko Oshiro et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Cooperative Regulation of Non-Small Cell Lung Carcinoma by Nicotinic and Beta-Adrenergic Receptors: A Novel Target for Intervention
Hussein A. N. Al-Wadei et al.
PLOS ONE (2012)
Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: Implications for anti-cancer drug targets
Hussein A. N. Al-Wadei et al.
PHARMACOLOGICAL RESEARCH (2012)
Continuous stress disrupts immunostimulatory effects of IL-12
Ben Levi et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
Sunil M. Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
Stanley Lemeshow et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Beta Blockers and Breast Cancer Mortality: A Population-Based Study
Thomas I. Barron et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
Amal Melhem-Bertrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TARGETED THERAPIES Using β-blockers to inhibit breast cancer progression
Desmond G. Powe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Erica K. Sloan et al.
CANCER RESEARCH (2010)
Impact of stress on cancer metastasis
Myrthala Moreno-Smith et al.
FUTURE ONCOLOGY (2010)
INFLUENCE OF TECHNOLOGIC ADVANCES ON OUTCOMES IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER RECEIVING CONCOMITANT CHEMORADIOTHERAPY
Zhongxing X. Liao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
Susan K. Lutgendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor
Ariella Glasner et al.
JOURNAL OF IMMUNOLOGY (2010)
Neuroendocrine modulation of cancer progression
Guillermo N. Armaiz-Pena et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and US Oncology
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B
Everett E. Vokes et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The neuroendocrine impact of chronic stress on cancer
Premal H. Thaker et al.
CELL CYCLE (2007)
NNK activates ERK1/2 and CREBATF-1 via β-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells
E. Laag et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers
D Palm et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Opinion - The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
MH Antoni et al.
NATURE REVIEWS CANCER (2006)
The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
JG Baker
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Beta-adrenergic modulation of NNK-induced lung carcinogenesis In hamsters
HM Schuller et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Share Paper
